SCHEMBL9704880

SCHEMBL9704880

c1ccc(C(NCCN2CCCCC2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 6/20 0.54
CHRM2 P08172 5/20 0.54
CHRM1 P11229 5/20 0.54
KCNH2 Q12809 4/20 0.54
HTR1A P08908 3/20 0.54
OPRM1 P35372 3/20 0.54
LMNA P02545 2/20 0.54
DPP7 Q9UHL4 1/20 0.51
SIGMAR1 Q99720 4/20 0.51
CHRM3 P20309 4/20 0.51
CHRM4 P08173 3/20 0.51
CHRM5 P08912 3/20 0.51
KDM4E B2RXH2 1/20 0.51
DRD2 P14416 1/20 0.51
DRD1 P21728 1/20 0.51
HTR2A P28223 1/20 0.51
DRD3 P35462 1/20 0.51
SCN1A P35498 1/20 0.51
SCN2A Q99250 1/20 0.51
SCN3A Q9NY46 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9703876 0.90 CHRM2 (0.56) CYP2D6CHRM2CHRM1KCNH2HTR1A
SCHEMBL14744149 0.83 CHRM2 (0.54) CYP2D6CHRM2CHRM1KCNH2HTR1A
SCHEMBL28307561 0.77 CHRM2 (0.51) CYP2D6CHRM2CHRM1KCNH2HTR1A
SCHEMBL12264131 0.74 KIF11 (0.74) KIF11KMT2AMEN1TSHRTDP1
SCHEMBL16176745 0.74 HTR7 (0.49) HTR1ASIGMAR1KDM4EMAPK1KMT2A
SCHEMBL8296146 0.73 DRD2 (0.61) HTR1ADRD2DRD3
SCHEMBL6699352 0.73 CHRM2 (0.74) CYP2D6CHRM2CHRM1KCNH2HTR1A
SCHEMBL8673780 0.73 POLB (0.59) DPP7SIGMAR1DRD3KMT2AMEN1
SCHEMBL11610162 0.73 CHRM2 (0.74) CYP2D6CHRM2CHRM1KCNH2HTR1A
Hydrochloric Acid SCHEMBL11093613 0.71 POLB (0.58) LMNADPP7SIGMAR1DRD3KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0480794-A1 2-Aminopyrimidine-4-carboxamide derivatives, their preparation and therapeutic use SYNTHELABO (FR) 1992-04-15 EP disclosed